FHWM
NVO

Fox Hill Wealth Management’s Novo Nordisk NVO Stock Holding History

Fox Hill Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,160
Closed -$425K – 130
2025
Q2 		$425K Sell
6,160
-225
-4% -$15.3K 0.22% 76
2025
Q1 		$443K Sell
6,385
-5,325
-45% -$440K 0.26% 71
2024
Q4 		$1.01M Sell
11,710
-18,638
-61% -$2.02M 0.57% 51
2024
Q3 		$3.61M Buy
30,348
+1,910
+7% +$255K 1.99% 10
2024
Q2 		$4.06M Buy
28,438
+118
+0.4% +$15.6K 2.48% 8
2024
Q1 		$3.64M Buy
28,320
+15,525
+121% +$1.85M 2.45% 9
2023
Q4 		$1.32M Buy
+12,795
New +$1.27M 1.02% 29

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fox Hill Wealth Management's NVO Position: Q3 2025 in Review

Fox Hill Wealth Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 6,160 shares — an estimated $425K sold.

Fox Hill Wealth Management first reported a position in NVO in Q4 2023 and held it in 7 quarters. The position peaked at $4.06M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Fox Hill Wealth Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Fox Hill Wealth Management sold 6,160 Novo Nordisk shares in Q3 2025, an estimated $425K.
  • Fox Hill Wealth Management first reported a position in Novo Nordisk in Q4 2023 and held it in 7 quarters.
  • Fox Hill Wealth Management's Novo Nordisk position peaked at $4.06M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Fox Hill Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.